0 CHECKOUT

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

  • ID: 3334728
  • June 2015
  • 206 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Akshaya Bio Inc.
  • BioDiem Ltd
  • Green Cross Corporation
  • Medicago Inc.
  • Novartis AG
  • SIGA Technologies, Inc.
  • MORE

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

Summary

This, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015’, provides an overview of the H5N1 Infection (Avian Influenza)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for H5N1 Infection (Avian Influenza), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H5N1 Infection (Avian Influenza) and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Akshaya Bio Inc.
  • BioDiem Ltd
  • Green Cross Corporation
  • Medicago Inc.
  • Novartis AG
  • SIGA Technologies, Inc.
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
H5N1 Infection (Avian Influenza) Overview
Therapeutics Development
Pipeline Products for H5N1 Infection (Avian Influenza) - Overview
Pipeline Products for H5N1 Infection (Avian Influenza) - Comparative Analysis
H5N1 Infection (Avian Influenza) - Therapeutics under Development by Companies
H5N1 Infection (Avian Influenza) - Therapeutics under Investigation by Universities/Institutes
H5N1 Infection (Avian Influenza) - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
H5N1 Infection (Avian Influenza) - Products under Development by Companies
H5N1 Infection (Avian Influenza) - Products under Investigation by Universities/Institutes
H5N1 Infection (Avian Influenza) - Companies Involved in Therapeutics Development
Akshaya Bio Inc.
AlphaVax, Inc.
Antigen Express, Inc.
Aphios Corporation
Aprogen, Inc.
BioDiem Ltd
CEL-SCI Corporation
Cocrystal Pharma, Inc.
Daiichi Sankyo Company, Limited
Emergent BioSolutions Inc.
Gemmus Pharma Inc.
GlaxoSmithKline Plc
Green Cross Corporation
Hemispherx Biopharma, Inc.
iBio, Inc.
Immunovaccine, Inc.
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Kineta, Inc.
Medicago Inc.
Medigen Biotechnology Corporation
Microgen Scientific Industrial Company for Immunobiological Medicines
Myelo Therapeutics GmbH
NanoBio Corporation
Nanotherapeutics, Inc.
NanoViricides, Inc.
NewLink Genetics Corporation
Novartis AG
OPKO Health, Inc.
PaxVax
PDS Biotechnology Corporation
PeptiDream Inc.
Protein Sciences Corporation
REPLICor Inc.
SIGA Technologies, Inc.
Sirnaomics, Inc.
Takeda Pharmaceutical Company Limited
TechnoVax, Inc.
Vaxart, Inc.
Vaxin, Inc.
Vaxine Pty Ltd
VaxInnate Corporation
H5N1 Infection (Avian Influenza) - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
A-06 - Drug Profile
AE-443p - Drug Profile
Alferon LDO - Drug Profile
APP-0205 - Drug Profile
APP-309 - Drug Profile
AT-301 - Drug Profile
CEL-1000 - Drug Profile
DP-C005 - Drug Profile
FBF-001 - Drug Profile
FDX-000 - Drug Profile
Gamma-Flu - Drug Profile
GP-1001 - Drug Profile
GP-1002 - Drug Profile
GP-1681 - Drug Profile
GREFLU/VIE - Drug Profile
HAI-05 - Drug Profile
iHA-24 - Drug Profile
Influ-nRNA - Drug Profile
influenza (strain H5N1, H1N1) vaccine - Drug Profile
influenza [strain A/H5N1] vaccine - Drug Profile
influenza [strain H5N1, H1N1] vaccine - Drug Profile
influenza [strain H5N1, H7N2, H9N2] virus like particle vaccine - Drug Profile
influenza [strain H5N1] (split virion) vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] vaccine - Drug Profile
influenza [strain H5N1] virus like particle vaccine + Glucopyranosyl Lipid A Adjuvant - Drug Profile
influenza A vaccine - Drug Profile
influenza vaccine - Drug Profile
influenza vaccine - Drug Profile
influenza vaccine - Drug Profile
influenza vaccine - Drug Profile
influezna [strain H5N1] virus like particles vaccine - Drug Profile
Innate Immune Adjuvants - Drug Profile
INO-3401 - Drug Profile
INO-3510 - Drug Profile
INO-3605 - Drug Profile
INO-3609 - Drug Profile
IPS-07 series - Drug Profile
JNJ-872 - Drug Profile
KD-295 - Drug Profile
KIB-PCI - Drug Profile
MG-1109 - Drug Profile
Monoclonal Antibody to Inhibit Hemagglutinin for Influenza - Drug Profile
MVAH-5HA - Drug Profile
Myelo-001 - Drug Profile
NVINF-1 - Drug Profile
NVINF-2 - Drug Profile
OrniFlu - Drug Profile
PanBlok - Drug Profile
PDS-0102 - Drug Profile
PNSIA-28 - Drug Profile
PNSIA-49 - Drug Profile
PXVX-0103 - Drug Profile
REP-9 - Drug Profile
rintatolimod - Drug Profile
Small Molecule for Influenza Virus - Drug Profile
Small Molecules to Activate Sirtuin for Influenza - Drug Profile
Small Molecules to Inhibit Endonuclease for Flu - Drug Profile
STP-702 - Drug Profile
Synthetic Peptides for Influenza, HSV and HIV Infections - Drug Profile
TVX-003 - Drug Profile
VAX-161 - Drug Profile
VH-244 - Drug Profile
H5N1 Infection (Avian Influenza) - Recent Pipeline Updates
H5N1 Infection (Avian Influenza) - Dormant Projects
H5N1 Infection (Avian Influenza) - Discontinued Products
H5N1 Infection (Avian Influenza) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for H5N1 Infection (Avian Influenza), H1 2015
Number of Products under Development for H5N1 Infection (Avian Influenza) - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Investigation by Universities/Institutes, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Akshaya Bio Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by AlphaVax, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Antigen Express, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Aphios Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Aprogen, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by BioDiem Ltd, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by CEL-SCI Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Cocrystal Pharma, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Daiichi Sankyo Company, Limited, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Emergent BioSolutions Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Gemmus Pharma Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by GlaxoSmithKline Plc, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Green Cross Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Hemispherx Biopharma, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by iBio, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Immunovaccine, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Inovio Pharmaceuticals, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Johnson & Johnson, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Kineta, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Medicago Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Medigen Biotechnology Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Microgen Scientific Industrial Company for Immunobiological Medicines, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Myelo Therapeutics GmbH, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by NanoBio Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Nanotherapeutics, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by NanoViricides, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by NewLink Genetics Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Novartis AG, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by OPKO Health, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by PaxVax, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by PDS Biotechnology Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by PeptiDream Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Protein Sciences Corporation, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by REPLICor Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by SIGA Technologies, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Sirnaomics, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by TechnoVax, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Vaxart, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Vaxin, Inc., H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by Vaxine Pty Ltd, H1 2015
H5N1 Infection (Avian Influenza) - Pipeline by VaxInnate Corporation, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
H5N1 Infection (Avian Influenza) Therapeutics - Recent Pipeline Updates, H1 2015
H5N1 Infection (Avian Influenza) - Dormant Projects, H1 2015
H5N1 Infection (Avian Influenza) - Dormant Projects (Contd..1), H1 2015
H5N1 Infection (Avian Influenza) - Dormant Projects (Contd..2), H1 2015
H5N1 Infection (Avian Influenza) - Dormant Projects (Contd..3), H1 2015
H5N1 Infection (Avian Influenza) - Dormant Projects (Contd..4), H1 2015
H5N1 Infection (Avian Influenza) - Discontinued Products, H1 2015

List of Figures
Number of Products under Development for H5N1 Infection (Avian Influenza), H1 2015
Number of Products under Development for H5N1 Infection (Avian Influenza) - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Akshaya Bio Inc.
AlphaVax, Inc.
Antigen Express, Inc.
Aphios Corporation
Aprogen, Inc.
BioDiem Ltd
CEL-SCI Corporation
Cocrystal Pharma, Inc.
Daiichi Sankyo Company, Limited
Emergent BioSolutions Inc.
Gemmus Pharma Inc.
GlaxoSmithKline Plc
Green Cross Corporation
Hemispherx Biopharma, Inc.
iBio, Inc.
Immunovaccine, Inc.
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Kineta, Inc.
Medicago Inc.
Medigen Biotechnology Corporation
Microgen Scientific Industrial Company for Immunobiological Medicines
Myelo Therapeutics GmbH
NanoBio Corporation
Nanotherapeutics, Inc.
NanoViricides, Inc.
NewLink Genetics Corporation
Novartis AG
OPKO Health, Inc.
PaxVax
PDS Biotechnology Corporation
PeptiDream Inc.
Protein Sciences Corporation
REPLICor Inc.
SIGA Technologies, Inc.
Sirnaomics, Inc.
Takeda Pharmaceutical Company Limited
TechnoVax, Inc.
Vaxart, Inc.
Vaxin, Inc.
Vaxine Pty Ltd
VaxInnate Corporation

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Maquet Getinge Group
  • Emergent BioSolutions, Inc.
  • Aicuris GmbH & Co.KG
  • Merck & Co., Inc.